Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication class of statins.
Pitavastatin is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.
It was patented in 1987 and approved for medical use in 2003. It is available in Japan, South Korea and in India. In the US, it received FDA approval in 2009.
Kowa Pharmaceuticals, a subsidiary of Kowa Company, is the owner of the American patent to pitavastatin. |
Read full article at Wikipedia
|
InChI=1S/C9H12N2O6/c12- 3- 4- 6(14) 7(15) 8(17- 4) 11- 2- 1- 5(13) 10- 9(11) 16/h1- 2,4,6- 8,12,14- 15H,3H2,(H,10,13,16) /t4- ,6- ,7- ,8- /m1/s1 |
DRTQHJPVMGBUCF-XVFCMESISA-N |
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(=O)[nH]c1=O |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Daphnia magna
(NCBI:txid35525)
|
See:
Mixtures of similarly acting compounds in Daphnia magna: From gene to metabolite and beyondTine Vandenbrouck, Oliver A.H. Jones, Nathalie Dom, Julian L. Griffin, Wim De CoenEnvironment International 36 (2010) 254-268
|
Saccharomyces cerevisiae
(NCBI:txid4932)
|
Source: yeast.sf.net
See:
PubMed
|
Escherichia coli
(NCBI:txid562)
|
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
DOI
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
drug metabolite
fundamental metabolite
Any metabolite produced by all living cells.
|
|
View more via ChEBI Ontology
1-β-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione
|
ChEBI
|
1-β-D-ribofuranosyluracil
|
HMDB
|
β-Uridine
|
HMDB
|
u
|
ChEBI
|
Urd
|
CBN
|
Uridin
|
ChemIDplus
|
Uridine
|
KEGG COMPOUND
|
URIDINE
|
PDBeChem
|
uridine
|
UniProt
|
397474
|
Gmelin Registry Number
|
Gmelin
|
58-96-8
|
CAS Registry Number
|
ChemIDplus
|
754904
|
Reaxys Registry Number
|
Reaxys
|
|